Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.
about
Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@en
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@nl
type
label
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@en
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@nl
prefLabel
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@en
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@nl
P2093
P2860
P1476
Sorafenib plus dacarbazine in ...... quential tumor biopsy samples.
@en
P2093
Carol Peña
Caroline Robert
Christophe Massard
Guillaume Meurice
Jean-Charles Soria
Jean-Pierre Armand
Marie-Aude Le Berre
Nathalie Lassau
Philippe Dessen
Thierry de Baere
P2860
P2888
P304
P356
10.1007/S10637-013-9993-0
P577
2013-08-27T00:00:00Z